Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://isaiahpxsh246768.timeblog.net/74746996/trelaglutide-exploring-a-new-treatment-for-chronic-diseases